Olema Pharmaceuticals, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.77 | -100% | -9.15 | -100% |
| P/S |
|
0 | 33.76 | -100% |
|
|
| P/BV |
|
2.6 | 4.82 | -46.03% |
|
|
| P/FCF |
|
-4.31 | 60.98 | -107.06% |
|
|
| Ev/Ebitda |
|
-5.68 | -22.12 | -74.3% |
|
|
| Ev/S |
|
0 | 22.56 | -100% |
|
|
| Ev/FCF |
|
-7.1 | 68.75 | -110.33% |
|
|
| E/P |
|
-0.268 | 0.0178 | -1607.85% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.83 | -100% | 0 | 0% |
| ROE |
|
-38.07 | 9.61 | -496.3% |
|
|
| ROA |
|
-34.9 | 0.3359 | -10489.96% |
|
|
| ROIC |
|
-26.57 | 7.63 | -448.03% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
-41.34 | 15.33 | -369.65% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0231 | -3.67 | -99.37% | -0.0356 | -35.12% |
| Nеt Debt/Ebitda |
|
0.6322 | -3.44 | -118.38% |
|
|
| Debt/Ratio |
|
0.0087 | 0.1972 | -95.57% |
|
|
| Debt/Equity |
|
1.61 | 1.65 | -2.13% |
|
|
| Debt/Net Income |
|
-0.025 | 10.31 | -100.24% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5496 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.1053 | -100% |
|
|
| DSI |
|
0 | 0.2174 | -100% |
|
|
| Average dividend growth |
|
0 | 0.0654 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4928 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5496 |
|
|
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % |
|---|---|---|---|---|
| Growth impulse Revenue 5 years |
0/10
|
0 | -56.89 | -100% |
| Growth impulse Ebitda 5 years |
|
2332.19 | -64.81 | -3698.5% |
| Growth impulse Net Income 5 years |
|
2147.79 | -58.33 | -3782.14% |
| Growth impulse FCF 5 years |
|
2600.87 | -47 | -5633.77% |
| Growth impulse EPS 5 years |
|
599 | -32.41 | -1948.2% |
IP Score
4.07/10
